Entropy Technologies LP Sells 16,071 Shares of Ventas, Inc. $VTR

Entropy Technologies LP cut its position in Ventas, Inc. (NYSE:VTR) by 15.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 88,926 shares of the real estate investment trust’s stock after selling 16,071 shares during the period. Entropy Technologies LP’s holdings in Ventas were worth $6,881,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its holdings in shares of Ventas by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after purchasing an additional 2,349,176 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Ventas by 1.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 29,701,300 shares of the real estate investment trust’s stock worth $2,078,794,000 after purchasing an additional 387,495 shares in the last quarter. State Street Corp grew its holdings in shares of Ventas by 2.5% during the 4th quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock worth $2,309,234,000 after purchasing an additional 735,620 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Ventas by 3.8% during the 4th quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after purchasing an additional 475,633 shares in the last quarter. Finally, Capital World Investors acquired a new stake in shares of Ventas during the 4th quarter worth $594,116,000. 94.18% of the stock is owned by institutional investors and hedge funds.

Ventas Price Performance

Shares of VTR stock opened at $84.58 on Friday. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a twelve month low of $61.76 and a twelve month high of $91.06. The company has a market cap of $41.12 billion, a P/E ratio of 153.79, a P/E/G ratio of 1.82 and a beta of 0.71. The business has a fifty day simple moving average of $85.15 and a 200 day simple moving average of $82.48.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the company earned $0.84 earnings per share. Ventas’s quarterly revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, sell-side analysts forecast that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Tuesday, June 30th. Ventas’s dividend payout ratio is currently 378.18%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on VTR. Mizuho set a $98.00 target price on Ventas in a report on Friday, May 22nd. Jefferies Financial Group increased their target price on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. The Goldman Sachs Group reissued a “buy” rating and set a $110.00 target price on shares of Ventas in a report on Tuesday, May 19th. Royal Bank Of Canada increased their target price on Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. Finally, Citigroup increased their target price on Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, May 1st. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $95.19.

Insider Buying and Selling at Ventas

In related news, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the sale, the director directly owned 28,349 shares in the company, valued at $2,557,079.80. This represents a 3.90% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.53% of the stock is owned by corporate insiders.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.